DK0701991T3 - Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil - Google Patents

Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Info

Publication number
DK0701991T3
DK0701991T3 DK95117572T DK95117572T DK0701991T3 DK 0701991 T3 DK0701991 T3 DK 0701991T3 DK 95117572 T DK95117572 T DK 95117572T DK 95117572 T DK95117572 T DK 95117572T DK 0701991 T3 DK0701991 T3 DK 0701991T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
chem
formula
ring
preparation
Prior art date
Application number
DK95117572T
Other languages
English (en)
Inventor
Sachio Mori
Shozo Takechi
Shiro Kida
Takuji Mizui
Teruhisa Ichihashi
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0701991T3 publication Critical patent/DK0701991T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/22—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one naphthalene or hydrogenated naphthalene ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
DK95117572T 1991-10-17 1992-10-15 Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil DK0701991T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29811991 1991-10-17

Publications (1)

Publication Number Publication Date
DK0701991T3 true DK0701991T3 (da) 1999-09-13

Family

ID=17855421

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92921331.2T DK0597107T3 (da) 1991-10-17 1992-10-15 Lignananalog, fremstilling deraf og hypolipidæmisk medikament
DK95117572T DK0701991T3 (da) 1991-10-17 1992-10-15 Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK92921331.2T DK0597107T3 (da) 1991-10-17 1992-10-15 Lignananalog, fremstilling deraf og hypolipidæmisk medikament

Country Status (12)

Country Link
US (4) US5420333A (da)
EP (2) EP0597107B1 (da)
JP (1) JP2839805B2 (da)
KR (1) KR100252428B1 (da)
AT (2) ATE139990T1 (da)
DE (2) DE69228262D1 (da)
DK (2) DK0597107T3 (da)
ES (2) ES2129733T3 (da)
GR (1) GR3020461T3 (da)
HU (1) HU211296A9 (da)
TW (1) TW209215B (da)
WO (1) WO1993008155A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646570B1 (en) * 1993-04-16 1998-06-24 Shionogi & Co., Ltd. Process for producing lignan compound
FR2707980B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux cyclohept[b]indoles et cyclooct[b]indoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
AU2353095A (en) * 1994-06-22 1996-01-15 Shionogi & Co., Ltd. Process for producing phthalide compound
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
CA2350213A1 (en) * 1998-11-12 2000-05-18 Alteon, Inc. Glucose and lipid lowering compounds
KR100352269B1 (ko) * 1999-10-08 2002-09-12 한국생명공학연구원 저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
FR2800738B1 (fr) 1999-11-04 2002-02-08 Corning Sa Naphtopyranes ayant un substituant perfluoroalkyle en position 5, preparation et compositions et matrices (co)polymeres les renfermant
US6770024B1 (en) * 2000-03-28 2004-08-03 Stony Brook Surgical Innovations, Inc. Implantable counterpulsation cardiac assist device
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
EP1749539A2 (en) * 2000-08-01 2007-02-07 Shionogi Co., Ltd. Preventives or remedies for fatty liver
JPWO2004033411A1 (ja) * 2002-10-08 2006-02-09 塩野義製薬株式会社 エノンエステルの製造法
US7152611B2 (en) * 2002-12-30 2006-12-26 International Tape Partners, Llc Coated multifilament dental devices overcoated with imbedded particulate
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP4137137A1 (en) 2010-05-26 2023-02-22 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EA038594B1 (ru) 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
EP4424363B1 (en) 2019-02-12 2026-04-29 Mirum Pharmaceuticals, Inc. Methods for increasing growth in pediatric subjects having cholestatic liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771072A (en) * 1985-01-10 1988-09-13 Tanabe Seiyaku Co., Ltd. Alkoxynaphthalene derivatives
JPS6310746A (ja) * 1986-07-01 1988-01-18 Tanabe Seiyaku Co Ltd ナフタレン誘導体
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤

Also Published As

Publication number Publication date
EP0597107A4 (en) 1994-02-03
HU211296A9 (en) 1995-11-28
EP0701991B1 (en) 1999-01-20
JPH05310634A (ja) 1993-11-22
US5420333A (en) 1995-05-30
KR100252428B1 (ko) 2000-04-15
US5731455A (en) 1998-03-24
ATE175954T1 (de) 1999-02-15
DE69211994D1 (de) 1996-08-08
GR3020461T3 (en) 1996-10-31
ES2129733T3 (es) 1999-06-16
EP0597107B1 (en) 1996-07-03
WO1993008155A1 (fr) 1993-04-29
KR930703236A (ko) 1993-11-29
TW209215B (da) 1993-07-11
JP2839805B2 (ja) 1998-12-16
ATE139990T1 (de) 1996-07-15
US5449814A (en) 1995-09-12
US5502216A (en) 1996-03-26
DE69211994T2 (de) 1997-02-20
DE69228262D1 (de) 1999-03-04
EP0597107A1 (en) 1994-05-18
ES2091488T3 (es) 1996-11-01
DK0597107T3 (da) 1996-07-29
EP0701991A1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
DK0597107T3 (da) Lignananalog, fremstilling deraf og hypolipidæmisk medikament
FI905215A0 (fi) Bensimidazolderivat, deras framstaellning och anvaendning.
ATE103592T1 (de) Carbamoylpyrrolidonderivate, ihre verwendung und herstellung.
NO881253D0 (no) 1,4-disubstituerte piperazinforbindelser og fremgangsmaate for deres fremstilling.
EE9400357A (et) Triasolopüridasiini ühendid, nende valmistamine ja kasutamine
EP0632031A4 (da)
TR24332A (tr) Fungisid olarak etkili akrilik asit tuerevleri
KR830007615A (ko) 피레트 린산과 연관된 시클로프로판 카복실산 에스테르와 그의 제조방법
ES2055077T3 (es) Un procedimiento para preparar derivados de amida de acido carboxilico.
ES2043807T3 (es) Compuestos anticancer.
FI882873A0 (fi) Tiofenderivat och foerfarande foer dess framstaellning.
DK0447135T3 (da) Fremgangsmåde til fremstilling af 1,5-benzothiazepinderivater
DK305879A (da) R fremgangsmaade til fremstilling af oxadiazolpyrimidinderivate
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
ES447910A1 (es) Procedimiento para la preparacion de derivados de acido car-bamico que contienen nitrogeno.
FI882874A0 (fi) Tiofenderivat och foerfarande foer dess framstaellning.
IE781734L (en) Preparation of derivatives of benzofuran, chromene and¹isochromene
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
JPS5653654A (en) Preparation of novel aniline derivative
ATE15659T1 (de) Synthese von indolinen.
DK0555481T3 (da) Tri(C1-C6-alkoxy)benzenderivat.
JPS56100785A (en) 1-azaerythrinan derivative
GB1326853A (en) 4,5-bis-trifluoromethylamino derivatives of thiazolidines and to a process for their preparation